Delineating role of ubiquitination on nuclear factor-kappa B pathway by a computational modeling approach
- 1. Cell Signaling and BioImaging Laboratory, Department of Bio and Brain Engineering, KAIST, Daejeon 305-701 (Korea, Republic of)
- 2. KI for Bio Century, KAIST, Daejeon 305-701 (Korea, Republic of)
- 3. Graduate School of Medical Science and Engineering, KAIST, Daejeon 305-701 (Korea, Republic of)
Description
Mutant ubiquitin found in neurodegenerative diseases has been thought to hamper activation of transcription factor nuclear factor-kappa B (NF-κB) by inhibiting ubiquitin-proteasome system (UPS). It has been reported that ubiquitin also is involved in signal transduction in an UPS-independent manner. We used a modeling and simulation approach to delineate the roles of ubiquitin on NF-κB activation. Inhibition of proteasome complex increased maximal activation of IKK mainly by decreasing the UPS efficiency. On the contrary, mutant ubiquitin decreased maximal activity of IKK. Computational modeling showed that the inhibition effect of mutant ubiquitin is mainly attributed to decreased activity of UPS-independent function of ubiquitin. Collectively, our results suggest that mutant ubiquitin affects NF-κB activation in an UPS-independent manner.
Availability note (English)
Available from http://dx.doi.org/10.1016/j.bbrc.2009.10.155Additional details
Identifiers
- DOI
- 10.1016/j.bbrc.2009.10.155;
- PII
- S0006-291X(09)02146-9;
Publishing Information
- Journal Title
- Biochemical and Biophysical Research Communications
- Journal Volume
- 391
- Journal Issue
- 1
- Journal Page Range
- p. 33-37
- ISSN
- 0006-291X
- CODEN
- BBRCA9
INIS
- Country of Publication
- United States
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 45020775
- Subject category
- S60: APPLIED LIFE SCIENCES;
- Descriptors DEI
- GENE REGULATION; INHIBITION; MUTANTS; NERVOUS SYSTEM DISEASES; SIGNALS; SIMULATION; TRANSCRIPTION FACTORS
- Descriptors DEC
- DISEASES; ORGANIC COMPOUNDS; PROTEINS
Optional Information
- Copyright
- Copyright (c) 2009 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.